Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis
- PMID: 34197741
- DOI: 10.1016/S1470-2045(21)00305-3
Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis
Conflict of interest statement
RP reports personal fees from Bristol Myers Squibb, MSD, Novartis, and Janssen, outside the submitted work. JL reports grants and personal fees from Achilles Therapeutics, Bristol Myers Squibb, MSD, Nektar, Immunocore, Pfizer, Roche, and Novartis; personal fees from AstraZeneca, Boston Biomedical, Eisai, EUSA Pharma, GSK, Ipsen, Imugene, Incyte, iOnctura, Kymab, Merck Sorono, Pierre Fabre, Secarna, Vitaccess, Covance; and grants from Aveo and Pharmacyclics, outside the submitted work. DLM reports personal fees from Bristol Myers Squibb, MSD, and Roche, outside the submitted work.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
